ST-920
ST-920-201
Phase 2 mab completed
Quick answer
ST-920 for Fabry Disease is a Phase 2 program (mab) at SANGAMO THERAPEUTICS, INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SANGAMO THERAPEUTICS, INC
- Indication
- Fabry Disease
- Phase
- Phase 2
- Modality
- mab
- Status
- completed